Would love for it to be true, but as there has been no announcement regarding this collaboration since 2018. Late last year Bob confirmed that would be using the test core sensors as was easier to fly the biopsy back to the US than to relocate or build a new sensor array in Australia.
Hughly bullish here and this technology is badly needed to eliminate this barbaric biopsyprocedure, but I am now understanding that timeframes for this tech need to be focused more out to 12 months time than 2-3 months when was expecting this trial to be finishing.
That said if they do any surprise announcement or even safety profile in first few patients the rerating will be massive, and I for one do not want to be left not holding a significant parcel.
IBX Price at posting:
9.2¢ Sentiment: Buy Disclosure: Held
